James Weitzman, MD, medical oncologist, Emerson Hospital and Waltham Cancer Center of Massachusetts General Cancer Center, discusses sequencing challenges in multiple myeloma treatment.
James Weitzman, MD
Advertisement
Articles by James Weitzman, MD
James Weitzman, MD, discusses sequencing challenges in multiple myeloma treatment.
James Weitzman, MD, discusses reusing treatments in patients with relapsed/refractory multiple myeloma.
James Weitzman, MD, discusses the challenges of treating patients with penta-refractory multiple myeloma.
Advertisement
Latest Updated Articles
Dr. Weitzman on Challenges of Treating Penta-Refractory Multiple MyelomaPublished: April 21st 2020 | Updated:
Dr. Weitzman on Reusing Treatments in Relapsed/Refractory Multiple MyelomaPublished: May 30th 2020 | Updated:
Dr. Weitzman on Sequencing Challenges in Myeloma TreatmentPublished: June 11th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
5